NCT05367440
Clinical Trial Detail

Request Content

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05367440
Title Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer (PETRANHA)
Acronym PETRANHA
Recruitment Active, not recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors AstraZeneca
Indications
prostate cancer
Therapies
Darolutamide + Saruparib
Abiraterone + Saruparib
Enzalutamide + Saruparib
Age Groups: adult | senior
Covered Countries USA | ITA | GBR | AUS

Facility Status City State Zip Country Details
Research Site Detroit Michigan 48201 United States Details
Research Site Detroit Michigan 48202 United States Details
Research Site Syracuse New York 13210 United States Details
Research Site Myrtle Beach South Carolina 29572 United States Details
Research Site Houston Texas 77030 United States Details
Research Site Houston Texas 77094 United States Details
Research Site Camperdown 2050 Australia Details
Research Site Darlinghurst 2010 Australia Details
Research Site East Melbourne 3002 Australia Details
Research Site Heidelberg 3084 Australia Details
Research Site Melbourne 3004 Australia Details
Research Site St Leonards 2065 Australia Details
Research Site Candiolo 10060 Italy Details
Research Site Milan 20133 Italy Details
Research Site Orbassano 10043 Italy Details
Research Site Padua 35128 Italy Details
Research Site Cambridge CB2 0QQ United Kingdom Details
Research Site Glasgow G12 0YN United Kingdom Details
Research Site Manchester M20 4BX United Kingdom Details
Research Site Plymouth PL6 8DH United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field